Obstructive sleep apnea (OSA) is a chronic condition in which enhancement of patient self-efficacy is critical for long-term management. One of the most important ways to help these patients manage their OSA is to effectively educate them about continuous positive airway pressure (CPAP), the most common and effective treatment for OSA, according to a research abstract that will be presented Wednesday at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).

Obstructive sleep apnea (OSA) is a major public health problem that, if untreated, can be deadly. Despite the proven reliability of continuous positive airway pressure (CPAP) in treating OSA, resistance and intolerance to CPAP poses limitations to its use.

Patients with both Alzheimer disease and a sleep related breathing disorder (SRBD) experience disrupted sleep, resulting in increased nocturnal awakenings and a decreased percentage of REM sleep.

In a study that examined the relationship between race, menopausal status and symptoms of obstructive sleep apnea (OSA), middle-aged African-American women were found to be more likely to experience OSA symptoms than their Caucasian counterparts, according to a research abstract that will be presented Monday at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies.

Adults with obstructive sleep apnea benefit significantly from longer nightly use of continuous positive airway pressure (CPAP), a device to improve breathing during sleep, according to a new study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

Researchers have found that patients with obstructive sleep apnea (OSA) have higher levels of a type of dead cells (apoptotic cells) from the lining (endothelium) of their blood vessels circulating in their bloodstream than people who do not have OSA. The finding may help explain why those with OSA are at higher risk for cardiovascular disease (CVD).

People with obstructive sleep apnea have a markedly increased risk of severe motor vehicle crashes involving personal injury, according to a study presented at the American Thoracic Society 2007 International Conference, on Sunday, May 20.

The nighttime breathing disorder known as obstructive sleep apnea increases a person's risk of having a heart attack or dying by 30% over a period of four to five years, according to a study presented at the American Thoracic Society 2007 International Conference, on Monday, May 21.

For the first time, a group based cognitive behavioural therapy (CBT) intervention has been demonstrated to markedly increase acceptance and adherence to CPAP treatment for sufferers of obstructive sleep apnea (OSA).